These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35854334)

  • 21. Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system.
    Ding Z; Harding CO; Rebuffat A; Elzaouk L; Wolff JA; Thöny B
    Mol Ther; 2008 Apr; 16(4):673-81. PubMed ID: 18362925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer.
    Ding Z; Georgiev P; Thöny B
    Gene Ther; 2006 Apr; 13(7):587-93. PubMed ID: 16319947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.
    Oh HJ; Park ES; Kang S; Jo I; Jung SC
    Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phenylketonuria patient: A recent dietetic therapeutic approach.
    Manta-Vogli PD; Dotsikas Y; Loukas YL; Schulpis KH
    Nutr Neurosci; 2020 Aug; 23(8):628-639. PubMed ID: 30359206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylketonuria oxidative stress and energy dysregulation: Emerging pathophysiological elements provide interventional opportunity.
    Dobrowolski SF; Phua YL; Vockley J; Goetzman E; Blair HC
    Mol Genet Metab; 2022 Jun; 136(2):111-117. PubMed ID: 35379539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Okano Y; Hase Y; Kawajiri M; Nishi Y; Inui K; Sakai N; Tanaka Y; Takatori K; Kajiwara M; Yamano T
    Pediatr Res; 2004 Nov; 56(5):714-9. PubMed ID: 15319459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging biosensors in Phenylketonuria.
    Shyam R; Sekhar Panda H; Mishra J; Jyoti Panda J; Kour A
    Clin Chim Acta; 2024 Jun; 559():119725. PubMed ID: 38734223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial.
    Muntau AC; Burlina A; Eyskens F; Freisinger P; Leuzzi V; Sivri HS; Gramer G; Pazdírková R; Cleary M; Lotz-Havla AS; Lane P; Alvarez I; Rutsch F
    Orphanet J Rare Dis; 2021 Aug; 16(1):341. PubMed ID: 34344399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New protein structures provide an updated understanding of phenylketonuria.
    Jaffe EK
    Mol Genet Metab; 2017 Aug; 121(4):289-296. PubMed ID: 28645531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector.
    Cerreto M; Mehdawy B; Ombrone D; Nisticò R; Ruoppolo M; Usiello A; Daniele A; Pastore L; Salvatore F
    Curr Gene Ther; 2012 Feb; 12(1):48-56. PubMed ID: 22348550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of Phenylketonuria: Then and Now.
    Blau N
    Hum Mutat; 2016 Jun; 37(6):508-15. PubMed ID: 26919687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.
    Rohr F; Burton B; Dee A; Harding CO; Lilienstein J; Lindstrom K; MacLeod E; Rose S; Singh R; van Calcar S; Whitehall K
    Mol Genet Metab; 2024 Mar; 141(3):108122. PubMed ID: 38184920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis.
    Zimmermann M; Jacobs P; Fingerhut R; Torresani T; Thöny B; Blau N; Baumgartner MR; Rohrbach M
    Mol Genet Metab; 2012 Jul; 106(3):264-8. PubMed ID: 22607939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
    Thöny B; Ding Z; Martínez A
    FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.
    Dobrowolski SF; Lyons-Weiler J; Spridik K; Vockley J; Skvorak K; Biery A
    Mol Genet Metab; 2016 Sep; 119(1-2):1-7. PubMed ID: 26822703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria.
    Manek R; Zhang YV; Berthelette P; Hossain M; Cornell CS; Gans J; Anarat-Cappillino G; Geller S; Jackson R; Yu D; Singh K; Ryan S; Bangari DS; Xu EY; Kyostio-Moore SRM
    Sci Rep; 2021 Nov; 11(1):22886. PubMed ID: 34819582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are Carriers Unaffected? A Literature Review of Metabolic and Health Outcomes among Genetic Carriers of Phenylketonuria.
    Khan SM; Heister RR; Keathley JR
    Lifestyle Genom; 2024; 17(1):102-112. PubMed ID: 39079504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
    Yano S; Moseley K; Fu X; Azen C
    PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.